Statin Use Does Not Affect Influenza Vaccine Effectiveness
Researchers assessed whether influenza vaccine effectiveness was affected by statin use, and whether statin use was associated with influenza infection.
Diagnosis & Disease Information
Wastewater Surveillance Uncovers Circulation of RSV, Influenza, Other Viruses
Researchers tested wastewater collected during the COVID-19 pandemic to assess the value of using RT-PCR assays targeting respiratory viral genomes on wastewater.
At-Home Combination Test for COVID-19, Flu Gets Emergency Use Authorization
The Lucira COVID-19 & Flu Home test is a single-use, nucleic acid amplification test intended for individuals with signs and symptoms consistent with a respiratory tract infection.
Rapid Influenza Diagnostic Testing May Improve Antibiotic Resistance
Researchers compared antiviral and antibiotic prescribing, imaging, and laboratory ordering in clinical encounters with and without rapid influenza diagnostic test results.
Common Viruses May Increase Long-Term Risk for Neurodegenerative Diseases
Researchers sought to examine potential associations between viral exposures and neurodegenerative disease risk.
RSV Surge: Bigger, Earlier, and Older Than Previous Seasonal Outbreaks
Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, certain features of this season’s outbreak set it apart from those of previous years.
Combo Vaccine Candidate for Influenza and COVID-19 Gets Fast Track Status
The combined vaccine is intended to simplify immunization practices against 2 severe respiratory diseases caused by evolving viruses that require vaccine adaptation.
COVID-19 Vaccine and Treatment Toolkit for Post-Acute and Long-Term Care Released
Toolkit provides guidance on the COVID-19 bivalent booster and oral antiviral therapeutics.
Nearly Half of Adults Not Planning or Hesitant to Get Flu Vaccine
NFID survey show beliefs about influenza and pneumococcal disease, as well as attitudes and practices around vaccination, including the impacts of the COVID-19 pandemic.
Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...